New release: LAMICAVIR

LAMICAVIR

Abacavir 600 mg + Lamivudine 300 mg
Coated tablets.

Single-tablet, fixed-dose formulation of two nucleoside-analog reverse transcriptase inhibitors.

Antiretroviral drug prequalified by the World Health Organization.

You must be logged in to post a comment.

Welcome to Laboratorio LIBRA, a dynamic Uruguayan company whith a responsible and committed relationship with health professionals and users.